Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic analysis of a Fanconi anemia case revealed the presence of FANCF mutation (exon 1;469>C-T) with implications to develop acute myeloid leukemia. | Mol Biol Rep | 2023 | 36369330 | PubTator, text mining | PubMed |
| Copy number variants suggest different molecular pathways for the pathogenesis of bladder exstrophy. | Am J Med Genet A | 2023 | 36349425 | PubTator, text mining | PubMed |
| Investigation of mutations in Fanconi anemia genes and malignancy predisposition in Brazilian patients. | Int J Lab Hematol | 2023 | 36333938 | PubTator, text mining | PubMed |
| Establishment, characterization and functional testing of two novel ex vivo extraskeletal myxoid chondrosarcoma (EMC) cell models. | Hum Cell | 2023 | 36316541 | PubTator, text mining | PubMed |
| The First Case of Acute Myeloid Leukemia With Underlying Fanconi Anemia due to FANCF Variants in Korea. | Ann Lab Med | 2023 | 36281516 | PubTator, text mining | PubMed |
| Two decades of stem cell transplantation in patients with Fanconi anemia: Analysis of factors affecting transplant outcomes. | Clin Transplant | 2023 | 36259220 | PubTator, text mining | PubMed |
| Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression on Novel Hormonal Therapies plus Avelumab. | Oncologist | 2023 | 36210487 | PubTator, text mining | PubMed |
| Molecular subtyping of small-cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies. | Cancer Sci | 2023 | 36178064 | PubTator, text mining | PubMed |
| DNA damage accumulation and repair defects in FLT3-ITD acute myeloid leukemia: Implications for clonal evolution and disease progression. | Hematol Oncol | 2023 | 36131612 | PubTator, text mining | PubMed |
| Validation of Pathogenicity of Gene Variants in Fanconi Anemia Using Patient-derived Dermal Fibroblasts. | Ann Lab Med | 2023 | 36045072 | PubTator, text mining | PubMed |
| Intraductal papillary neoplasm of the bile duct: Cytomorphologic and molecular features. | Cancer Cytopathol | 2023 | 36041224 | PubTator, text mining | PubMed |
| A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma. | J Clin Oncol | 2023 | 35960902 | PubTator, text mining | PubMed |
| Multiple primary melanoma in association with other personal and familial cancers. | Cancer Med | 2023 | 35932099 | PubTator, text mining | PubMed |
| Treatment Planning for Atrial Fibrillation Using Patient-Specific Models Showing the Importance of Fibrillatory-Areas. | Ann Biomed Eng | 2023 | 35930093 | PubTator, text mining | PubMed |
| Cancer carrier screening in the general population using whole-genome sequencing. | Cancer Med | 2023 | 35861108 | PubTator, text mining | PubMed |
| Genomic Signatures from Clinical Tumor Sequencing in Patients with Breast Cancer Having Germline BRCA1/2 Mutation. | Cancer Res Treat | 2023 | 35681111 | PubTator, text mining | PubMed |
| A tribute to Fanconi: 'clinical acumen still counts'. | Haematologica | 2023 | 35417941 | PubTator, text mining | PubMed |
| Genotype-phenotype and outcome associations in patients with Fanconi anemia: the National Cancer Institute cohort. | Haematologica | 2023 | 35417938 | PubTator, text mining | PubMed |
| The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients. | J Cancer Res Clin Oncol | 2023 | 35220468 | PubTator, text mining | PubMed |
| Community-based house improvement for malaria control in southern Malawi: Stakeholder perceptions, experiences, and acceptability. | PLOS Glob Public Health | 2022 | 36962454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=32